APO Research
Talk to an analyst

APO RESEARCH · REPORT

Montelukast Sodium Tablet

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Montelukast Sodium Tablet Market Outlook and Growth Opportunities 2026

29 December 2025191 pages

Choose your research edition.

Industry ResearchMontelukast Sodium Tablet Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Montelukast Sodium Tablet Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Montelukast Sodium Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Montelukast Sodium Tablet Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Montelukast Sodium Tablet Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Montelukast Sodium Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Montelukast Sodium Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Montelukast Sodium Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Montelukast Sodium Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Montelukast Sodium Tablet market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Montelukast Sodium Tablet market include Jiangsu Vanguard Pharmaceutical Co.,Ltd., Organon Pharma (UK) Limited, Lunan Better Pharmaceutical Co.,Ltd, Otsuka, Shanghai Anbisheng Pharmaceutical Technology Co. Ltd, Taiwan Biotech Co., Ltd, Sandoz Private Limited and N.V. Organon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Montelukast Sodium Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Montelukast Sodium Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Montelukast Sodium Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Montelukast Sodium Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.

Montelukast Sodium Tablet Segment by Company

Jiangsu Vanguard Pharmaceutical Co.,Ltd.

Organon Pharma (UK) Limited

Lunan Better Pharmaceutical Co.,Ltd

Otsuka

Shanghai Anbisheng Pharmaceutical Technology Co. Ltd

Taiwan Biotech Co., Ltd

Sandoz Private Limited

N.V. Organon

Montelukast Sodium Tablet Segment by Type

Original Drug

Generic Drug

Montelukast Sodium Tablet Segment by Application

Hospital

Pharmacy

Others

Montelukast Sodium Tablet Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Montelukast Sodium Tablet status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Montelukast Sodium Tablet market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Montelukast Sodium Tablet significant trends, drivers, influence factors in global and regions.

6. To analyze Montelukast Sodium Tablet competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast Sodium Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Montelukast Sodium Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast Sodium Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Montelukast Sodium Tablet market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Montelukast Sodium Tablet industry.

Chapter 3: Detailed analysis of Montelukast Sodium Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Montelukast Sodium Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Montelukast Sodium Tablet in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Montelukast Sodium Tablet Industry Trends Table 2. Montelukast Sodium Tablet Industry Drivers Table 3. Montelukast Sodium Tablet Industry Opportunities and Challenges Table 4. Montelukast Sodium Tablet Industry Restraints Table 5. Global Montelukast Sodium Tablet Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Montelukast Sodium Tablet Revenue Share by Company (2021-2026) Table 7. Global Montelukast Sodium Tablet Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Montelukast Sodium Tablet Sales Volume Share by Company (2021-2026) Table 9. Global Montelukast Sodium Tablet Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Montelukast Sodium Tablet Company Ranking, (2024-2026) & (USD Million) Table 11. Global Montelukast Sodium Tablet Key Company Manufacturing Base & Headquarters Table 12. Global Montelukast Sodium Tablet Company, Product Type & Application Table 13. Global Montelukast Sodium Tablet Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Montelukast Sodium Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Original Drug Table 18. Significant Companies of Generic Drug Table 19. Global Montelukast Sodium Tablet Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Montelukast Sodium Tablet Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Montelukast Sodium Tablet Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Montelukast Sodium Tablet Sales Volume Share by Type (2021-2026) Table 23. Global Montelukast Sodium Tablet Sales Volume Share by Type (2027-2032) Table 24. Global Montelukast Sodium Tablet Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Montelukast Sodium Tablet Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Montelukast Sodium Tablet Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Montelukast Sodium Tablet Sales Value Share by Type (2021-2026) Table 28. Global Montelukast Sodium Tablet Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Pharmacy Table 31. Significant Companies of Others Table 32. Global Montelukast Sodium Tablet Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Montelukast Sodium Tablet Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Montelukast Sodium Tablet Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Montelukast Sodium Tablet Sales Volume Share by Application (2021-2026) Table 36. Global Montelukast Sodium Tablet Sales Volume Share by Application (2027-2032) Table 37. Global Montelukast Sodium Tablet Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Montelukast Sodium Tablet Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Montelukast Sodium Tablet Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Montelukast Sodium Tablet Sales Value Share by Application (2021-2026) Table 41. Global Montelukast Sodium Tablet Sales Value Share by Application (2027-2032) Table 42. Global Montelukast Sodium Tablet Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Montelukast Sodium Tablet Sales by Region (2021-2026) & (K Units) Table 44. Global Montelukast Sodium Tablet Sales Market Share by Region (2021-2026) Table 45. Global Montelukast Sodium Tablet Sales by Region (2027-2032) & (K Units) Table 46. Global Montelukast Sodium Tablet Sales Market Share by Region (2027-2032) Table 47. Global Montelukast Sodium Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Montelukast Sodium Tablet Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Montelukast Sodium Tablet Sales Value Share by Region (2021-2026) Table 50. Global Montelukast Sodium Tablet Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Montelukast Sodium Tablet Sales Value Share by Region (2027-2032) Table 52. Global Montelukast Sodium Tablet Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Montelukast Sodium Tablet Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Montelukast Sodium Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Montelukast Sodium Tablet Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Montelukast Sodium Tablet Sales by Country (2021-2026) & (K Units) Table 57. Global Montelukast Sodium Tablet Sales Market Share by Country (2021-2026) Table 58. Global Montelukast Sodium Tablet Sales by Country (2027-2032) & (K Units) Table 59. Global Montelukast Sodium Tablet Sales Market Share by Country (2027-2032) Table 60. Global Montelukast Sodium Tablet Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Montelukast Sodium Tablet Sales Value Market Share by Country (2021-2026) Table 62. Global Montelukast Sodium Tablet Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Montelukast Sodium Tablet Sales Value Market Share by Country (2027-2032) Table 64. Jiangsu Vanguard Pharmaceutical Co.,Ltd. Company Information Table 65. Jiangsu Vanguard Pharmaceutical Co.,Ltd. Business Overview Table 66. Jiangsu Vanguard Pharmaceutical Co.,Ltd. Montelukast Sodium Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Jiangsu Vanguard Pharmaceutical Co.,Ltd. Montelukast Sodium Tablet Product Portfolio Table 68. Jiangsu Vanguard Pharmaceutical Co.,Ltd. Recent Development Table 69. Organon Pharma (UK) Limited Company Information Table 70. Organon Pharma (UK) Limited Business Overview Table 71. Organon Pharma (UK) Limited Montelukast Sodium Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Organon Pharma (UK) Limited Montelukast Sodium Tablet Product Portfolio Table 73. Organon Pharma (UK) Limited Recent Development Table 74. Lunan Better Pharmaceutical Co.,Ltd Company Information Table 75. Lunan Better Pharmaceutical Co.,Ltd Business Overview Table 76. Lunan Better Pharmaceutical Co.,Ltd Montelukast Sodium Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Lunan Better Pharmaceutical Co.,Ltd Montelukast Sodium Tablet Product Portfolio Table 78. Lunan Better Pharmaceutical Co.,Ltd Recent Development Table 79. Otsuka Company Information Table 80. Otsuka Business Overview Table 81. Otsuka Montelukast Sodium Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Otsuka Montelukast Sodium Tablet Product Portfolio Table 83. Otsuka Recent Development Table 84. Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Company Information Table 85. Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Business Overview Table 86. Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Montelukast Sodium Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Montelukast Sodium Tablet Product Portfolio Table 88. Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Recent Development Table 89. Taiwan Biotech Co., Ltd Company Information Table 90. Taiwan Biotech Co., Ltd Business Overview Table 91. Taiwan Biotech Co., Ltd Montelukast Sodium Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Taiwan Biotech Co., Ltd Montelukast Sodium Tablet Product Portfolio Table 93. Taiwan Biotech Co., Ltd Recent Development Table 94. Sandoz Private Limited Company Information Table 95. Sandoz Private Limited Business Overview Table 96. Sandoz Private Limited Montelukast Sodium Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Sandoz Private Limited Montelukast Sodium Tablet Product Portfolio Table 98. Sandoz Private Limited Recent Development Table 99. N.V. Organon Company Information Table 100. N.V. Organon Business Overview Table 101. N.V. Organon Montelukast Sodium Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. N.V. Organon Montelukast Sodium Tablet Product Portfolio Table 103. N.V. Organon Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Montelukast Sodium Tablet Distributors List Table 107. Montelukast Sodium Tablet Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Montelukast Sodium Tablet Product Image Figure 2. Global Montelukast Sodium Tablet Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Montelukast Sodium Tablet Sales Value (2021-2032) & (US$ Million) Figure 4. Global Montelukast Sodium Tablet Sales (2021-2032) & (K Units) Figure 5. Global Montelukast Sodium Tablet Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Montelukast Sodium Tablet Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Original Drug Image Figure 10. Generic Drug Image Figure 11. Global Montelukast Sodium Tablet Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Montelukast Sodium Tablet Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Montelukast Sodium Tablet Sales Volume Share by Type (2021-2032) Figure 14. Global Montelukast Sodium Tablet Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Montelukast Sodium Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Montelukast Sodium Tablet Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Pharmacy Image Figure 19. Others Image Figure 20. Global Montelukast Sodium Tablet Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Montelukast Sodium Tablet Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Montelukast Sodium Tablet Sales Volume Share by Application (2021-2032) Figure 23. Global Montelukast Sodium Tablet Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Montelukast Sodium Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Montelukast Sodium Tablet Sales Value Share by Application (2021-2032) Figure 26. Global Montelukast Sodium Tablet Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Montelukast Sodium Tablet Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Montelukast Sodium Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Montelukast Sodium Tablet Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Montelukast Sodium Tablet Sales Value (2021-2032) & (US$ Million) Figure 31. North America Montelukast Sodium Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Montelukast Sodium Tablet Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Montelukast Sodium Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Montelukast Sodium Tablet Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Montelukast Sodium Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Montelukast Sodium Tablet Sales Value (2021-2032) & (US$ Million) Figure 37. South America Montelukast Sodium Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Montelukast Sodium Tablet Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Montelukast Sodium Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Montelukast Sodium Tablet Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Montelukast Sodium Tablet Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Jiangsu Vanguard Pharmaceutical Co.,Ltd.
  • Organon Pharma (UK) Limited
  • Lunan Better Pharmaceutical Co.,Ltd
  • Otsuka
  • Shanghai Anbisheng Pharmaceutical Technology Co. Ltd
  • Taiwan Biotech Co., Ltd
  • Sandoz Private Limited
  • N.V. Organon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Montelukast Sodium Tablet Sales Value (2021-2032)
  4. 1.2.2 Global Montelukast Sodium Tablet Sales Volume (2021-2032)
  5. 1.2.3 Global Montelukast Sodium Tablet Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Montelukast Sodium Tablet Market Dynamics
  1. 2.1 Montelukast Sodium Tablet Industry Trends
  2. 2.2 Montelukast Sodium Tablet Industry Drivers
  3. 2.3 Montelukast Sodium Tablet Industry Opportunities and Challenges
  4. 2.4 Montelukast Sodium Tablet Industry Restraints
3 Montelukast Sodium Tablet Market by Company
  1. 3.1 Global Montelukast Sodium Tablet Company Revenue Ranking in 2025
  2. 3.2 Global Montelukast Sodium Tablet Revenue by Company (2021-2026)
  3. 3.3 Global Montelukast Sodium Tablet Sales Volume by Company (2021-2026)
  4. 3.4 Global Montelukast Sodium Tablet Average Price by Company (2021-2026)
  5. 3.5 Global Montelukast Sodium Tablet Company Ranking (2024-2026)
  6. 3.6 Global Montelukast Sodium Tablet Company Manufacturing Base and Headquarters
  7. 3.7 Global Montelukast Sodium Tablet Company Product Type and Application
  8. 3.8 Global Montelukast Sodium Tablet Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Montelukast Sodium Tablet Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Montelukast Sodium Tablet Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Montelukast Sodium Tablet Market by Type
  1. 4.1 Montelukast Sodium Tablet Type Introduction
  2. 4.1.1 Original Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Montelukast Sodium Tablet Sales Volume by Type
  5. 4.2.1 Global Montelukast Sodium Tablet Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Montelukast Sodium Tablet Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Montelukast Sodium Tablet Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Montelukast Sodium Tablet Sales Value by Type
  9. 4.3.1 Global Montelukast Sodium Tablet Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Montelukast Sodium Tablet Sales Value by Type (2021-2032)
  11. 4.3.3 Global Montelukast Sodium Tablet Sales Value Share by Type (2021-2032)
5 Montelukast Sodium Tablet Market by Application
  1. 5.1 Montelukast Sodium Tablet Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Montelukast Sodium Tablet Sales Volume by Application
  6. 5.2.1 Global Montelukast Sodium Tablet Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Montelukast Sodium Tablet Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Montelukast Sodium Tablet Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Montelukast Sodium Tablet Sales Value by Application
  10. 5.3.1 Global Montelukast Sodium Tablet Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Montelukast Sodium Tablet Sales Value by Application (2021-2032)
  12. 5.3.3 Global Montelukast Sodium Tablet Sales Value Share by Application (2021-2032)
6 Montelukast Sodium Tablet Regional Sales and Value Analysis
  1. 6.1 Global Montelukast Sodium Tablet Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Montelukast Sodium Tablet Sales by Region (2021-2032)
  3. 6.2.1 Global Montelukast Sodium Tablet Sales by Region: 2021-2026
  4. 6.2.2 Global Montelukast Sodium Tablet Sales by Region (2027-2032)
  5. 6.3 Global Montelukast Sodium Tablet Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Montelukast Sodium Tablet Sales Value by Region (2021-2032)
  7. 6.4.1 Global Montelukast Sodium Tablet Sales Value by Region: 2021-2026
  8. 6.4.2 Global Montelukast Sodium Tablet Sales Value by Region (2027-2032)
  9. 6.5 Global Montelukast Sodium Tablet Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Montelukast Sodium Tablet Sales Value (2021-2032)
  12. 6.6.2 North America Montelukast Sodium Tablet Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Montelukast Sodium Tablet Sales Value (2021-2032)
  15. 6.7.2 Europe Montelukast Sodium Tablet Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Montelukast Sodium Tablet Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Montelukast Sodium Tablet Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Montelukast Sodium Tablet Sales Value (2021-2032)
  21. 6.9.2 South America Montelukast Sodium Tablet Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Montelukast Sodium Tablet Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Montelukast Sodium Tablet Sales Value Share by Country, 2025 VS 2032
7 Montelukast Sodium Tablet Country-level Sales and Value Analysis
  1. 7.1 Global Montelukast Sodium Tablet Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Montelukast Sodium Tablet Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Montelukast Sodium Tablet Sales by Country (2021-2032)
  4. 7.3.1 Global Montelukast Sodium Tablet Sales by Country (2021-2026)
  5. 7.3.2 Global Montelukast Sodium Tablet Sales by Country (2027-2032)
  6. 7.4 Global Montelukast Sodium Tablet Sales Value by Country (2021-2032)
  7. 7.4.1 Global Montelukast Sodium Tablet Sales Value by Country (2021-2026)
  8. 7.4.2 Global Montelukast Sodium Tablet Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Montelukast Sodium Tablet Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Montelukast Sodium Tablet Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Montelukast Sodium Tablet Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Jiangsu Vanguard Pharmaceutical Co.,Ltd.
  2. 8.1.1 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Company Information
  3. 8.1.2 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Business Overview
  4. 8.1.3 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Montelukast Sodium Tablet Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Montelukast Sodium Tablet Product Portfolio
  6. 8.1.5 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Recent Developments
  7. 8.2 Organon Pharma (UK) Limited
  8. 8.2.1 Organon Pharma (UK) Limited Company Information
  9. 8.2.2 Organon Pharma (UK) Limited Business Overview
  10. 8.2.3 Organon Pharma (UK) Limited Montelukast Sodium Tablet Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Organon Pharma (UK) Limited Montelukast Sodium Tablet Product Portfolio
  12. 8.2.5 Organon Pharma (UK) Limited Recent Developments
  13. 8.3 Lunan Better Pharmaceutical Co.,Ltd
  14. 8.3.1 Lunan Better Pharmaceutical Co.,Ltd Company Information
  15. 8.3.2 Lunan Better Pharmaceutical Co.,Ltd Business Overview
  16. 8.3.3 Lunan Better Pharmaceutical Co.,Ltd Montelukast Sodium Tablet Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Lunan Better Pharmaceutical Co.,Ltd Montelukast Sodium Tablet Product Portfolio
  18. 8.3.5 Lunan Better Pharmaceutical Co.,Ltd Recent Developments
  19. 8.4 Otsuka
  20. 8.4.1 Otsuka Company Information
  21. 8.4.2 Otsuka Business Overview
  22. 8.4.3 Otsuka Montelukast Sodium Tablet Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Otsuka Montelukast Sodium Tablet Product Portfolio
  24. 8.4.5 Otsuka Recent Developments
  25. 8.5 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd
  26. 8.5.1 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Company Information
  27. 8.5.2 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Business Overview
  28. 8.5.3 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Montelukast Sodium Tablet Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Montelukast Sodium Tablet Product Portfolio
  30. 8.5.5 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Recent Developments
  31. 8.6 Taiwan Biotech Co., Ltd
  32. 8.6.1 Taiwan Biotech Co., Ltd Company Information
  33. 8.6.2 Taiwan Biotech Co., Ltd Business Overview
  34. 8.6.3 Taiwan Biotech Co., Ltd Montelukast Sodium Tablet Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Taiwan Biotech Co., Ltd Montelukast Sodium Tablet Product Portfolio
  36. 8.6.5 Taiwan Biotech Co., Ltd Recent Developments
  37. 8.7 Sandoz Private Limited
  38. 8.7.1 Sandoz Private Limited Company Information
  39. 8.7.2 Sandoz Private Limited Business Overview
  40. 8.7.3 Sandoz Private Limited Montelukast Sodium Tablet Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sandoz Private Limited Montelukast Sodium Tablet Product Portfolio
  42. 8.7.5 Sandoz Private Limited Recent Developments
  43. 8.8 N.V. Organon
  44. 8.8.1 N.V. Organon Company Information
  45. 8.8.2 N.V. Organon Business Overview
  46. 8.8.3 N.V. Organon Montelukast Sodium Tablet Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 N.V. Organon Montelukast Sodium Tablet Product Portfolio
  48. 8.8.5 N.V. Organon Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Montelukast Sodium Tablet Value Chain Analysis
  2. 9.1.1 Montelukast Sodium Tablet Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Montelukast Sodium Tablet Sales Mode & Process
  6. 9.2 Montelukast Sodium Tablet Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Montelukast Sodium Tablet Distributors
  9. 9.2.3 Montelukast Sodium Tablet Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst